Sera from patients in our immunotherapy program are evaluated by testing in the primary culture inhibition test (PCI), which we describe here as a sensitive indicator of antitumor activity in these sera. A variant of the PCI test, in which blood leukocytes are used, is also described.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً